Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Inhibitors (4)

Isotope-Labeled Compounds Related Products (9980):

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-W744058

Vardenafil Oxopiperazine (Impurity)-d₆
Vardenafil Oxopiperazine (Impurity)-d₆ is the deuterium labeled Vardenafil Oxopiperazine (Impurity).

HY-W739664

9-[2-(Diethylphosphonomethoxy)propyl-d₆] adenine
9-[2-(Diethylphosphonomethoxy)propyl-d₆] adenine is the deuterium labeled 9-[2-(Diethylphosphonomethoxy)propyl] adenine.

HY-A0042S1

Rufinamide-¹⁵N,d₂
Rufinamide-¹⁵N,d₂ (CGP 33101-¹⁵N,d₂) is the deuterium and ¹⁵N labeled Rufinamide (HY-A0042).Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na⁺ current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome.

HY-W767371

8-Bromoguanosine-¹³C,¹⁵N₂
8-Bromoguanosine-¹³C,¹⁵N₂ is the ¹³C- and ¹⁵N-labeled 8-Bromoguanosine (HY-W019033). 8-Bromoguanosine is a purine nucleoside, a brominated derivative of guanosine. 8-Bromoguanosine can reduce the conformational heterogeneity of RNA to enhance its function.

HY-N0830S17

Palmitic acid-d₂-4
Palmitic acid-d₂-4 is the deuterium labeled Palmitic acid. Palmitic acid is a long-chain saturated fatty acid commonly found in both animals and plants. PA can induce the expression of glucose-regulated protein 78 (GRP78) and CCAAT/enhancer binding protein homologous protein (CHOP) in in mouse granulosa cells.

HY-79131S1

Fmoc-Phe-OH-¹³C₉,¹⁵N		99.33%
Fmoc-Phe-OH-¹³C₉,¹⁵N is a ¹⁵N-labeled and ¹³C-labled Fmoc-Phe-OH (HY-79131). Fmoc-Phe-OH is a phenylalanine derivative.

HY-W052227S

Fmoc-DL-Ala-OH-d
Fmoc-DL-Ala-OH-d is the deuterium labeled DL-Alanine-2-N-fmoc.

HY-W714629

4-(Dimethylamino)butanoic acid-d₆ hydrochloride
4-(Dimethylamino)butanoic acid-d₆ hydrochloride is the deuterium labeled 4-(Dimethylamino)butanoic acid hydrochloride (HY-W007989).

HY-W585809S1

2-Chloropropane-1,3-diyl distearate-d₅ (major)
2-Chloropropane-1,3-diyl distearate-d5 (major) is a deuterated labeled 2-Chloropropane-1,3-diyl distearate.

HY-N7092S13

D-Fructose-¹³C₆,d₇
D-Fructose-¹³C₆,d₇ is the deuterium and ¹³C labeled D-Fructose. D-Fructose (D(-)-Fructose) is a naturally occurring monosaccharide found in many plants.

HY-W766920

Olsalazine Disodium-¹³C₁₂
Olsalazine disodium-¹³C₁₂ is the ¹³C-labeled Olsalazine disodium (HY-B0174). Olsalazine Disodium is an anti-inflammatory compound that works in inflammatory bowel disease and ulcerative colitis.

HY-W705168

Yangonin-d₃
Yangonin-d₃ is the deuterium labeled Yangonin (HY-N0919). Yangonin exhibits affinity for the human recombinant cannabinoid CB1 receptor with an IC₅₀ and a Ki of 1.79 μM and 0.72 μM, respectively.

HY-A0114S

Moexiprilat-d₅
Moexiprilat-d₅ is deuterium labeled Moexiprilat.

HY-W751156

O-Phospho-L-serine-¹³C₃
O-Phospho-L-serine-¹³C₃ (L-Serine O-phosphate-¹³C₃) is the ¹³C-labeled O-Phospho-L-serine (HY-15129). O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2.

HY-W013812S3

Ethyl linoleate-d₁₁
Ethyl linoleate-d₁₁ (Linoleic Acid ethyl ester-d₁₁) is deuterium labeled Ethyl linoleate. Ethyl linoleate (Linoleic Acid ethyl ester) inhibit the development of atherosclerotic lesions and the expression of inflammatory mediators.

HY-143790S

N-2-(Hydroxyethyl)-L-valine-d₄
N-2-(Hydroxyethyl)-L-valine-d₄ is the deuterium labeled N-2-(Hydroxyethyl)-L-valine.

HY-15037S

Diclofenac-¹³C₆ sodium heminonahydrate
Diclofenac-¹³C₆ (sodium heminonahydrate) is the ¹³C-labeled Diclofenac Sodium. Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC₅₀s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade.

HY-10053S

Maropitant-d₃
Maropitant-d₃ is the deuterium labeled Maropitant. Maropitant is a selective and orally active neurokinin (NK1) receptor antagonist. Maropitant acts by blocking the binding of substance P within the emetic center and the chemoreceptor trigger zone (CRTZ). Maropitant is highly effective in preventing vomiting.

HY-W007928S

1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-¹³C
1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-¹³C is the ¹³C labeled D-Ribulose.

HY-W005355S

Sodium 2-oxobutanoate-¹³C₄,d₂ hydrate
Sodium 2-oxobutanoate-¹³C₄,d₂ (hydrate) is the deuterium and ¹³C labeled Sodium 2-oxobutanoate hydrate.

Name
Email *

	Sorry, but the email address you supplied was invalid.